Kora Healthcare is an innovative company committed to developing healthcare products across a spectrum of therapeutic areas. These include medicines that treat or manage secondary conditions arising from, relating to and complicated by underlying serious, chronic and long-term diseases such as our high solubility magnesium salt products and the first ever UK licenced selenium supplement. Additionally, Kora has recently launched Salifluss in the UK, a muco-adhesive tablet designed for the treatment of symptoms from Xerostomia. For information on these, or our other products, please visit our experts on stand G30.